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Abstract
Background: Children dying of a life threatening disease suffer a great deal at the end of life. Symptom control is
often unsatisfactory, partly because many caregivers are simply not familiar with paediatric palliative care. To ensure
that a child with a life-threatening condition receives high quality palliative care, clinical practice guidelines are
needed. The aim of this study is to improve palliative care for children by making high quality care
recommendations to recognize and relieve symptoms in paediatric palliative care.
Methods: An extensive search was performed for guidelines and systematic reviews on paediatric palliative care up
to year 2011. An expert panel combined the evidence with consensus to form recommendations on the treatment
of symptoms in paediatric palliative care.
Results: We appraised 21 guidelines and identified 693 potentially eligible articles of which four met our inclusion
criteria. None gave recommendations on the treatment of symptoms in paediatric palliative care. Two textbooks
and an adult palliative care website were eventually our main sources of evidence.
Conclusion: Hardly any evidence is available for the treatment of symptoms in paediatric palliative care. By
combining evidence for adult palliative care and the sparse evidence for paediatric palliative care with expert
opinion we defined a unique set of high quality care recommendations to relieve symptoms and lessen the
suffering of children in palliative care. These results are an important tool to educate caregivers on how to relieve
symptoms in children in paediatric palliative care.
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Background
Tens of thousands of children die each year in high in-
come countries from trauma, prematurity, heritable dis-
orders, and acquired illnesses. Even more children are
coping with life-threatening conditions [1]. All these
children need high quality palliative care. The American
Academy of Paediatrics (AAP) has clearly stated that
paediatric palliative care should be directed at the im-
provement of the quality of life of children dealing with
a life-threatening condition and their families. Palliative
care should be aimed at the prevention and relief of suf-
fering by early identification and treatment of symptoms
of physical, psychosocial, or spiritual nature and should
be started at diagnosis and continued during the period
of illness, irrespective of the outcome, either cure or
death [2, 3]. All paediatricians, general physicians, and
related professionals should become familiar with the
provision of palliative care to children [3]. In paediatric
palliative care greater attention should be given to symp-
tom control and the overall wellbeing to lessen the suf-
fering of children whose conditions make it unlikely that
they will live into adulthood [4]. To ensure that children
with a life-threatening condition receive high quality pal-
liative care, clinical practice guidelines are needed. The
aim of this study is to improve palliative care for chil-
dren by making a systematic review with high quality
care recommendations to recognize and relieve symp-
toms in paediatric palliative care.
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Methods
No written informed consent was needed for this study.
The manual of the Dutch Evidence Based Guideline De-
velopment platform (EBRO platform) [5] was used for the
methodology to develop a guideline, based on a systematic
review with high quality care recommendations, for paedi-
atric palliative care. After selection of topics, a step wise
approach was followed to search in scientific literature for
evidence in paediatric palliative care.
Selection of topics
An expert panel consisting of different stakeholders in
paediatric palliative care in the Netherlands was assem-
bled. We asked the scientific associations of specialties
that provide paediatric palliative care to select experts
from different centres, whom we approached to partici-
pate in the expert panel. This expert panel was composed
of 22 members and consisted of paediatric oncologists,
paediatric neurologists, nurses, anaesthesiologists, psy-
chologists, a hospice doctor, a palliative care specialist, a
paediatric critical care specialist, a general practitioner, a
physician for people with intellectual disabilities, health
care managers, and patient/parent representatives. The
expert panel was asked to create an inventory of the main
symptoms during paediatric palliative care.
Search for evidence
As a first step in our quest for evidence in paediatric
palliative care we searched for guidelines in websites of
international health care and guideline development or-
ganizations. The databases of Sumsearch (Medline,
DARE, National Guideline Clearinghouse), Clinical
Evidence of the BMJ group, Scottish Intercollegiate
Guidelines Network (SIGN), and the Trip database
were searched for paediatric palliative care guidelines
up to year 2011. Selection of guidelines was based on
title and carried out by two independent reviewers
(M.U. and L.V.). The following inclusion criteria were
used: 1) guideline directed at children (0 to 18 years of
age) or adult guideline with separate recommendations
for children, 2) guideline about palliative care (MESH-
term). Palliative care guidelines for premature infants
(gestational age less than 26 weeks) or resuscitation
were excluded. The reason that palliative care for pre-
mature infants was excluded from this study, is that
palliative care for this group of children takes place in
a different setting (mainly neonatal intensive care
units), with different symptoms and different symptom
management. [6]. Resuscitation guidelines were ex-
cluded because they generally on unexpected, acute
events, while the focus of our study was planned
decision-making and palliative care in paediatric life
threatening conditions. Members of the expert panel
were also asked to supply additional guidelines.
As a second source for evidence we looked for system-
atic reviews on paediatric palliative care. The databases
of Medline/Pubmed and The Cochrane Library were
searched for systematic reviews on paediatric palliative
care up to year 2011. The search strategy combined con-
trolled vocabulary and text word terms for palliative
care, children and systematic review. The search strategy
is listed in Additional file 1: appendix 1. Data extraction
of the included systematic reviews on paediatric pallia-
tive care was performed by two independent reviewers
(M.U. and L.V.).
For the third and last step in our search for evidence in
paediatric palliative care we used the sources most fre-
quently used in daily practice in the Netherlands: two text-
books on paediatric palliative care (Wolfe [7], Goldman
[8]) and the Pallialine website [9] (Dutch website with
guidelines for adult palliative care).
To focus on high quality evidence that already has
been integrated in guidelines and systematic reviews, we
did not perform a systematic literature search for ori-
ginal studies in paediatric palliative care.
Quality assessment
All retrieved guidelines were independently evaluated by
two reviewers using the AGREE instrument [10]. Ap-
praisal of guidelines by the AGREE-instrument can have
as outcome that a guideline is recommended, not rec-
ommended or that recommendation is unclear. For this
study we decided to include the recommended guidelines
and the guidelines for which recommendation was un-
clear. By this measure we could also include guidelines
based on multidisciplinary expert opinion in subjects
where evidence is not available.
Quality assessment of the included systematic reviews
on paediatric palliative care was performed by two inde-
pendent reviewers and was based on the critical ap-
praisal checklist of the CoCanCPG-project [11].
Quality assessment of the items that were derived
from the textbooks [7, 8] and the Pallialine website [9]
was done by two independent reviewers by checking the
references. The level of evidence was based on the man-
ual of the Dutch Evidence Based Guideline Development
platform (EBRO-platform) [5] as shown in Table 1.
Recommendations
The strength of a recommendation depends on the level
of evidence and/or on general agreement [12]. The ex-
pert panel was asked to extend the evidence that re-
sulted from our extensive search in literature with their
expert opinion. The experts were able to reach consen-
sus on all items. To combine the level of evidence with
consensus we categorized the recommendations using
the 3-colour scheme adapted from the American Heart
Association [12].
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Green is used for strong recommendations, based on
high quality evidence (level 1 or 2) for children or for
recommendations that can be extrapolated from high
quality evidence (level 1 or 2) for adults, or for recom-
mendations based on general agreement. The benefits of
a green recommendation outweigh its disadvantages.
Green recommendations should be performed.
Orange is used for an intermediate level of recommen-
dations based on a moderate/weak level of evidence
(level 3 or lower) for children or for recommendations
that can be extrapolated from moderate/weak level of
evidence (level 3 or lower) for adults, or for recommen-
dations based on general agreement. The benefits are
equal to or possibly outweigh the disadvantages. Orange
recommendations should be considered.
Red is used for strong recommendations to avoid or
prevent particular interventions. Red recommendations
are based on high quality evidence (level 1 or 2) for chil-
dren or for recommendations that can be extrapolated
from high quality evidence (level 1 or 2) for adults, or
for recommendations based on general agreement. Red
recommendations have no benefits and possibly do
harm. Red recommendations warn for interventions
that should not be performed (Table 2). If evidence was
conflicting and/or the expert panel could not reach con-
sensus on the matter the term “controversy” was used.
Controversial recommendations were omitted from the
list of recommendations or were listed as recommenda-
tions to be considered.
Results
Selection of topics
According to the expert panel inventory the main symp-
toms during paediatric palliative care that need to be ad-
dressed in a paediatric palliative care guideline are, in
alphabetical order: 1) anxiety and depression, 2) bleeding
and anaemia, 3) coughing and rattling, 4) dyspnoea, 5)
fatigue, 6) nausea and vomiting, 7)neurological symp-
toms, 8) pain, and 9) pruritus.
Search for evidence
The search for paediatric palliative guidelines in the web-
sites of international health care and guideline develop-
ment organizations identified a total of 21 potentially
eligible guidelines. These 21 guidelines were appraised by
the AGREE-instrument [10]. Eight guidelines were recom-
mended after appraisal by the AGREE-instrument.
All of these guidelines gave recommendations about de-
cision making in paediatric palliative care. But none of
these recommended guidelines gave recommendations
about recognizing and treating symptoms in paediatric
palliative care.
The search for systematic reviews on paediatric pallia-
tive care in the databases of Medline/Pubmed and The
Cochrane Library identified 693 potentially eligible arti-
cles. Screening the titles and abstracts of these articles
excluded 673 articles. The remaining 20 articles were re-
trieved in full text for more detailed examination. Four
[13–16] of the retrieved articles met all inclusion criteria
and were used for data extraction. None of these system-
atic reviews gave recommendations about recognizing
and treating symptoms in paediatric palliative care. The
two textbooks on paediatric palliative care (Wolfe [7],
Goldman [8]) and the Pallialine website [9] were eventu-
ally our main sources of evidence on recognizing and
treating symptoms in paediatric palliative care. The evi-
dence tables for the treatment of each symptom that was
listed as main topic by our expert panel are depicted in
Additional file 1: Appendix 3.
Recommendations
The recommendations, based on evidence and/or con-
sensus, for the treatment of symptoms of each topic are
listed in Table 3.
Table 1 Level of evidence for interventions
Level of evidence Evidence is based on:
Level 1 Systematic review or at least two randomized clinical trials of good quality
Level 2 One randomized clinical trial or at least two case–control studies
Level 3 One case–control study or one cohort study
Level 4 Textbook or expert opinion
Table 2 Levels of evidence and strength of recommendation
Grading of Recommendation
Level of evidence Do Consider Don’t
Level 1 Strong Recommendation Strong Recommendation
Level 2 Strong Recommendation Strong Recommendation
Level 3 Moderate Recommendation
Expert opinion Strong Recommendation Moderate Recommendation Strong Recommendation
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Discussion
Hardly any evidence is available for the treatment of
symptoms in paediatric palliative care. By maintaining a
systematic approach we were able to define a unique set
of high quality care recommendations to relieve symp-
toms and lessen the suffering of children in palliative
care. Although care for children differs immensely from
adult care, literature on adult palliative care is the main
source from which recommendations for paediatric pallia-
tive care can be deduced from. By combining evidence for
adult palliative care and the sparse evidence for paediatric
palliative care with paediatric expert opinion we defined
recommendations for treating symptoms in paediatric pal-
liative care.
Paediatric palliative care is complex. The management
of the physical, psychosocial, and spiritual needs of a
child with a life threatening condition is intense and dif-
ficult. Palliative care for children is, in comparison with
adults, also relatively rare and views on how to handle
and cope with dying children differ in many cultures.
This complexity and rarity requires a specialized multidis-
ciplinary approach to deliver optimal care [17]. Caregivers
dealing with a child in palliative care should be able to
consult paediatric palliative care teams, especially in case
of pain management. As paediatric palliative care teams
are not widely or immediately available, caregivers dealing
with a child in palliative care need to know how to man-
age symptoms [18]. Children dying of a life threatening
disease suffer a great deal at the end of life. Symptom con-
trol in children dying of cancer is often unsatisfactory at
this stage of disease [4]. Symptom control could benefit
from greater awareness, prevention, and early recognition
of symptoms by caregivers in paediatric palliative care.
Better treatment of symptoms is also necessary to ease the
suffering of children with life-threatening conditions. The
results of this study are an important tool to educate
caregivers who are inexperienced in palliative care for
children. These recommendations can be used as a
guideline and will help to make decisions on the treatment
of symptoms in children with life-threatening conditions
in high income countries.
In the last decade many standards, guidelines and quality
improvement strategies have been developed for adult pal-
liative care. This has been a major contribution to the inte-
gration of palliative care into daily practice and has
improved the quality of adult palliative care [19]. Because of
its complexity and rarity, paediatric palliative care has seen
a much slower progress. Local initiatives have tried to give
guidance in paediatric palliative care, but standardization of
care is lacking. By using an expert panel consisting of many
members with different professional backgrounds, we pro-
vided broad multidisciplinary support on a national level
for the standardization of the recommendations on the
treatment of symptoms in paediatric palliative care.
The recommendations on the treatment of symptoms
in paediatric palliative care were categorized according
to a colour scheme: green for “do”, orange for “consider”
and red for “don’t”. Evidence for green and red recom-
mendations is of a high enough level that no further dis-
cussion is needed whether these recommendations
should or respectively should not be performed. Atten-
tion should be called to the orange recommendations.
As the effectiveness of orange recommendations is un-
clear, shared decision making is needed to decide
whether these recommendations should be performed or
not. Future research should be directed at the questions
raised by the orange recommendations and should clar-
ify whether they should be recommended or should be
avoided.
This study will be helpful in the international debate
on improving the care for children with life-threatening
conditions. Palliative care is a wide concept which also
encompasses end-of-life care. Decision making in the
last stage of life is difficult and is complicated by delicate
ethical, legal, religious, and political issues. In the
Netherlands, decisions to actively end a patient’s life be-
cause of hopeless and unbearable suffering have been
formalized in laws and other regulations, both for adults
and for new-borns [20, 21]. It seemed odd that this spe-
cific part of end-of-life care received so much attention,
while there were no formal guidelines available for the
palliative care for children in the Netherlands. Our ap-
proach can be seen as an important step towards closing
the gap between treatment of suffering in children in the
context of palliative care and end-of-life care.
A limitation of this study is the lack of evidence in
symptom control in paediatric palliative care, which also
indicates the lack of our knowledge in general on this
matter. To keep a broad outlook on paediatric palliative
care and to focus on high quality evidence that already
has been integrated in guidelines and systematic reviews,
we did not perform a systematic literature search for ori-
ginal studies in paediatric palliative care. This implies
that evidence from studies which have not (yet) been in-
cluded in systematic reviews and guidelines could have
been missed.
As mentioned above the main source of evidence for
recommendations for paediatric palliative care was adult
palliative care literature. As literature on adult palliative
care is predominantly oriented towards cancer, the recom-
mendations in this study focus also on symptoms experi-
enced in cancer. The range of symptoms experienced in
paediatric palliative care differ however in cancer and
non-cancer patients [22]. Taken into account that the ma-
jority of children in palliative care in North America have
non-cancer diagnoses [23, 24] it should be stated that this
study does not cover the full range of symptoms that may
be encountered in paediatric palliative care.
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Table 3 Recommendations for treatment of symptoms in
paediatric palliative care
- Anxiety and depression
Do • Consult a psychologist, paediatric psychiatrist, if necessary a
physician for people with intellectual disabilities or someone
of a similar discipline.
• Decide in deliberation with the parents the mode of
treatment for the anxiety and/or depression of the child.
• Involve a spiritual caregiver (possibly of the family’s own
conviction) to help with existential philosophical questions.
• Offer relaxation and distraction techniques in case of anxiety.
Consider • Consider selective serotonin reuptake inhibitors (SSRI’s) in
case of anxiety, whether or not accompanied by depression.
• Consider methylphenidate in case of depression.
• Consider the help of experts for self-hypnosis.
- Bleeding and anaemia
Do • In case of mild bleeding and shortage of coagulation factors
give desmopressin, tranexamic acid and/or vitamin K.
• In case of severe bleeding give fresh frozen plasma and/or
recombinant factor VII.
• In case of a life threatening bleeding and DNR-order explain
symptoms and treat dyspnoea with morphine, diazepam or
midazolam.
• In case of thrombosis give low molecular weight heparin.
Consider • Consider blood transfusion in anaemia (Hb<5,0 mmol/L).
• Consider desmopressin for bleeding caused by mild
thrombocytopenia.
• Consider for nose bleeds local adrenalin, xylometazolin,
spongostan or local coagulation by an ENT-physician.
• Consider in case of bleeding platelet transfusions.
• Consider transfusions of platelets before physical activities.
• Consider heparin in case of thrombosis.
Don’t • Do not give vitamins and/or nutritional supplements.
• Do not give erythropoietin.
- Coughing and rattling
Do Coughing
• Give counselling and do breathing exercises.
• Give morphine if coughing leads to discomfort.
Consider Coughing
• Consider codeine, dextromethorphan or noscapin.
• Consider physical therapy for productive coughing.
• Consider “huffing” (breathing technique in which expiration
is performed with open glottis).
• Consider expirational compression of thorax.
• Consider different postures (coughing while standing or
sitting is more effective).
• Consider inhalation of physiological saline (NaCl 0.9 %).
Rattling
• Consider suction.
• Consider lying on one’s side.
• Consider anti-cholinergic medication.
Table 3 Recommendations for treatment of symptoms in
paediatric palliative care (Continued)
- Dyspnoea
Do • Give information and do breathing exercises
• Create a calm and quiet atmosphere
• Give morphine if dyspnoea leads to discomfort
Consider • Consider referral to physical therapist for “Neuro electrical
muscle stimulation and chest wall vibration”.
• Consider the use of a fan to cool the face.
• Consider the use of experts for self-hypnosis.
• Consider the use of lorazepam or midazolam, in
combination with morphine to lessen the experienced
discomfort, especially in case of anxiety.
• Consider inhalation of physiological saline (NaCl 0.9 %) or
hypertonic saline (NaCl 3 %) in case of thick mucus.
• Consider the inhalation of corticosteroids, airway dilators
and mucolytic drugs in case of bronchial obstruction and/or
asthma.
• Consider the supply of oxygen.
Don’t • Do not nebulize morphine.
- Fatigue
Do • Treat electrolyte disorders, dehydration and/or
malnourishment.
• Treat comorbidity like asthma, infection, pain and/or pruritus.
• Discuss in case of depression counselling and
antidepressants.
• Encourage a regular sleep-wake rhythm and avoid
stimulants.
• Give advices for relaxation and distraction.
• Give psycho education for managing fatigue.
• Emphasize the importance of the balance between physical
activities and rest.
• Focus on what the child can do and not on what he/she is
unable to do anymore.
• Keep a diary to get insight in fatigue and activities.
• Advise fatigue reducing activities.
• Advise a regular sleeping scheme.
• Consult a physical therapist for an exercise program.
Consider • Consider corticosteroids.
• Consider melatonin for sleeping disorders.
• Consider blood transfusion if haemoglobin drops below
5 mmol/l.
• Consider short lasting treatment with benzodiazepines for
sleeping disorders.
• Consider stopping medication which might have fatigue as
side effect.
• Consider the treatment of other underlying symptoms.
• Consider stimulating bedridden children to get out of bed
regularly.
• Consider consulting a psychologist for psychotherapy or
support.
• If all of the above does not help, consider methylphenidate.
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The list of recommendations for the treatment of
symptoms in paediatric palliative care was used to de-
velop the Dutch guideline for paediatric palliative care,
which also addresses decision making and the organisa-
tion of paediatric palliative care in the Netherlands [25].
This guideline was approved by a broad selection of sci-
entific associations who all participate in the palliative
care for children in the Netherlands (Additional file 1:
Appendix 2). As mentioned above, the search for for
paediatric palliative care guidelines was performed in the
year 2011. Paediatric palliative care guidelines published
after 2011 will be included after discussion in the revi-
sion and extension of the Dutch guideline for paediatric
palliative care [26, 27].
Table 3 Recommendations for treatment of symptoms in
paediatric palliative care (Continued)
- Nausea and vomiting
Do • Distract the child, especially in case of anxiety.
• Combine non-medical treatment with medical treatment.
Consider • Consider dietary advice.
• Consider consultation of a physical therapist, psychologist
and/or music therapist.
• Consider hypnosis.
• Consider a step-wise approach in medical treatment:
Step 1:
• 5-HT3-receptor antagonist and/or
• D2-receptor antagonist
• H1-, and ACh-receptor antagonists
Step 2:
• Corticosteroids
• Low dose benzodiazepine
• Replace a step 1 drug with another member of the same
family of drugs (rotation).





• Low dose propofol
- Neurological symptoms
Do Seizures
• Give midazolam or diazepam in case of seizures lasting over
5 min or in case of several short seizures.
• Consult a paediatric neurologist.
Diplopia
• Give an eye patch.
Non-closure of (one of ) the eyes
• Give during the day methylcellulose eye drops.
• Give at night oculentem simplex eye ointment.
Swallowing disorders
• Try to prevent aspiration.
• Give optimal feeding fitting the stage of disease.
• Offer fluids with a straw.
• Make sure there are pauses between swallowing.
• Let the child sit straight.
Consider Seizures
• Consider maintenance treatment, like clonazepam,
levetiracetam, valproic acid, carbamazepine, phenobarbital,
clobazam, phenytoin or midazolam.
Non-seizure movements
• Consider consulting a paediatric neurologist.
• Consider bipiridene to treat acute dystonia caused by
anti-emetics.
Table 3 Recommendations for treatment of symptoms in
paediatric palliative care (Continued)
• Consider baclofen or benzodiazepines to treat unpleasant
movements.
• Consider injecting botulinum toxins for treatment of local
spasticity.
Swallowing disorders
• Consider a nasogastric tube to prevent aspiration.
• Consider a nasogastric tube to guarantee intake.
• Consider thickening of the food.
- Pain
Do • Treat pain according to a set (time) scheme, use the most
suitable way and adjust to the needs of the child.
Consider • Consider melatonin for headaches and sleeping disorders.
• Consider complementary therapies.
- Pruritus
Do • Prevent intertrigo.
• Treat crusting with damp towels.
• Give ointments for dry skin.
• Give ointments with anti-pruritus supplements (menthol).
• Give ointments with corticosteroids for eczema.
• Give disinfectants, anti-fungal and/or antibiotic ointments for
infected skin.
• In case of opioid-associated pruritus give opioid antagonists
or rotate opioids.
Consider • Consider cooling the skin.
• Consider hypnosis.
• Consider antihistamines.
• Consider serotonin antagonists.
• Consider H2-receptor antagonists.
• Consider additional chemotherapy and/or steroids for
lymphoma-associated pruritus.
• In case of cholestasis-associated pruritus consider stenting,
H2-receptor antagonists, mirtazapine, serotonin antagonists,
rifampicin, phenobarbital, cholestyramine, ursodeoxylcholic
acid or prednisone (if there are no other solutions).
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Although the importance of good palliative care re-
ceives a growing amount of interest, the focus of re-
search has been mainly on the organization of palliative
care and not on the management of symptoms. As men-
tioned above, hardly any evidence is available on symp-
tom control in paediatric palliative care. Randomized
controlled trials in palliative care are complicated because
of many methodological difficulties and ethical issues [28].
Because of these issues randomized trials are often consid-
ered inappropriate or even not possible in palliative care.
Well-designed observational studies can provide valuable
information in palliative care [29]. An enormous task
awaits researchers to fill out the gaps in this field.
Conclusions
In conclusion, by combining evidence for adult palliative
care and the sparse evidence for paediatric palliative care
with paediatric expert opinion we were able to define an
extensive list of recommendations for the treatment of
symptoms in paediatric palliative care. Paediatric pallia-
tive care should be directed at the improvement of the
quality of life of children dealing with a life-threatening
condition and their families. The results of this study can
be used as a guideline and are an important tool to edu-
cate caregivers on how to relieve symptoms in children
with life threatening conditions and improve quality of
paediatric palliative care in high income countries.
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